Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02080650 · ClinicalTrials.gov registry record · NA
Characterization of Circulating Tumor Cells Captured by c-MET (CTC-MET)
A NA study, sponsored by Duke University.
- Completed
- Registry status
- NA
- Development phase
- 62
- Enrollment target
NCT02080650: Completed NA study, sponsored by Duke University.
NCT02080650 is a NA study that has completed, run by Duke University. The registered enrollment target is 62 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02080650, a NA study, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- NA
- Development phase
- 62 participants
- Enrollment target
Study Summary
This pilot study will aim to determine whether circulating tumor cells (CTCs) can be captured using the novel cMET based ferrofluid. The primary objective of this pilot study will be to describe the numbers of c-MET expressing cells that can be detected by the c-MET CTC capture technique. These data will be separated by disease site. The investigator will also describe the detection rates of both the c-MET CTC capture and the EpCAM CTC capture techniques in each patient, also separated by disease site.
Primary Outcome
Feasibility as measured by successfully detecting at least one CTC in at least 2 out of 10 subjects within each disease site.
Interventions
- DEVICE Mesenchymal-marker based ferrofluid (c-MET)
- DEVICE Epithelial cell adhesion molecule (EpCAM) ferrofluid
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 62 participants |
| Start Date | 2014-03 |
| Est. Completion | 2016-07-19 |
| Phase | NA |
What the finished NCT02080650 record still lists
NCT02080650 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 62 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 2 interventions - of which Mesenchymal-marker based ferrofluid (c-MET) is the first listed.
NCT02080650 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02080650 about?
NCT02080650 is a clinical study titled "Characterization of Circulating Tumor Cells Captured by c-MET (CTC-MET)". This pilot study will aim to determine whether circulating tumor cells (CTCs) can be captured using the novel cMET based ferrofluid. The primary objective of this pilot study will be to describe the numbers of c-MET expressing cells that can be detected by the c-MET CTC capture technique. These data...
What is the current status of trial NCT02080650?
This trial is currently completed. It is a NA study. The enrollment target is 62 participants. The study started on 2014-03. Estimated completion is 2016-07-19.
What interventions are being tested in trial NCT02080650?
The interventions under investigation include: Mesenchymal-marker based ferrofluid (c-MET) (DEVICE), Epithelial cell adhesion molecule (EpCAM) ferrofluid (DEVICE).
Who is sponsoring clinical trial NCT02080650?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02080650's enrollment target sits among peer trials
62 1157th of 2000 higher than 837 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03231150 · 62 participants · NA
Plantar Fasciitis Randomized Clinical Control Trial
- NCT03458676 · 62 participants · NA
Radiologic Pathologic Correlation of Advanced MR Imaging to Guide the Biopsy of Cerebral Malignancies
- NCT03596086 · 62 participants · Phase 1
HSV-tk + Valacyclovir + SBRT + Chemotherapy for Recurrent GBM
- NCT03603405 · 62 participants · Phase 1
HSV-tk and XRT and Chemotherapy for Newly Diagnosed GBM
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia